Table C2.
National number of diagnoses and median reliability of complete-case composite and site-specific early stage indicators for general practices, CCGs and local authorities, with number of years of data at current completeness levels required for reliable indicators for 70% of organisations.
| Cancer site | Tumours |
Median reliability |
Years of data required for reliable indicators (λ ≥ 0.7) for 70% of organisations |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Staged | Stage 1–2 | GP | CCG | LA | GP | CCG | LA | |
| All ten sites combined | 208,141 | 172,001 | 98,780 | 0.12 | 0.66 | 0.61 | 30.2 | 1.5 | 2.0 |
| Breast | 44,558 | 37,465 | 31,635 | 0.08 | 0.59 | 0.42 | 28.7 | 2.3 | 4.8 |
| Prostate | 39,934 | 32,859 | 19,422 | 0.05 | 0.71 | 0.62 | 75.3 | 1.3 | 1.9 |
| Lung | 35,972 | 31,234 | 7307 | 0.02 | 0.44 | 0.32 | 142.0 | 4.0 | 7.0 |
| Colorectal | 33,477 | 27,719 | 12,398 | 0.04 | 0.26 | 0.15 | 92.0 | 8.7 | 17.3 |
| Melanoma | 12,245 | 10,520 | 9591 | 0.10 | 0.26 | 0.19 | 34.0 | 9.7 | 19.2 |
| NHL | 11,222 | 8080 | 2916 | 0.33 | 0.24 | 7.0 | 10.8 | ||
| Endometrial | 7232 | 6615 | 5405 | 0.10 | 0.06 | 30.6 | 50.1 | ||
| Bladder | 8669 | 6505 | 4835 | 0.25 | 0.14 | 10.3 | 22.7 | ||
| Renal | 8368 | 5970 | 3202 | 0.28 | 0.21 | 8.1 | 13.4 | ||
| Ovarian | 6464 | 5034 | 2069 | 0.14 | 0.14 | 20.7 | 21.6 | ||